Thursday, October 15, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 15, 2026

Heavy Metal Testing Market Projected to Reach US$ 7,130.12 Million by 2035, Supported by Regulatory Testing Requirements Says Astute Analytica

View original at globenewswire.com
Heavy Metal Testing Market Projected to Reach US$ 7,130.12 Million by 2035, Supported by Regulatory Testing Requirements Says Astute Analytica Chicago, Jan…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Heavy metal contamination specifically triggered 13 distinct recall events in 2024

    80% confidence

  • Consumer Reports investigation found concerning levels of lead and cadmium in one-third of dark chocolate products tested

    80% confidence

  • Organic protein powders contained 3 times more lead than non-organic versions

    80% confidence

  • The global heavy metal testing market size was valued at USD 3,880 million in 2025 and is projected to hit the market valuation of USD 7,130.12 million by 2035 at a CAGR of 6.80% during the forecast period 2026–2035

    80% confidence

  • CrossLab service division reported 5% revenue growth

    80% confidence

  • 25% increase in certified pre-owned instrument volume in 2024

    80% confidence

  • Agilent saw high-40s percentage growth in its PFAS business

    80% confidence

  • Fishery products, particularly tuna, drove 4% of RASFF notifications due to heavy metals

    80% confidence

  • Agilent has install base reaching approximately 285,000 laboratories worldwide

    80% confidence

  • Turkey was identified as the #1 country of origin for RASFF notifications, followed by Egypt and India

    80% confidence

  • 296 food recalls recorded in 2024, where contaminant failures caused 1,392 illnesses and 19 deaths

    80% confidence

  • Agilent refurbished 5,400 instruments in 2024

    80% confidence

  • Chocolate-flavored plant-based powders harbored 110 times more cadmium than vanilla options

    80% confidence

  • Border rejections accounted for 33% of all EU RASFF notifications

    80% confidence

  • EU network flagged 550 suspected cases of food fraud in 2024

    80% confidence

  • 40% of Agilent's instrument revenue came from products bearing My Green Lab ACT labels

    80% confidence

  • 47% of 160 tested protein powders exceeded safety limits

    80% confidence

  • EU's RASFF system recorded a 12% increase in notifications, totaling 5,250 in 2024, with heavy metals ranking as the 4th most frequent hazard category

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com
Heavy Metal Testing Market Projected to Reach US$ 7,130.12 Million by 2035, Supported by Regulatory Testing Requirements Says Astute Analytica — Source | Via News | Via News